No more applications are being accepted for this job
- Gather input for all EUR/INT and global deals (neuroscience and oncology) across key EUR/INT stakeholders in marketing, medical, pricing/access, regulatory, and regional general management roles to inform commercial business case
- Evaluate commercial synergies and strategic fit with the EUR/INT portfolio, including sales force and SG&A requirements
- Develop executive-level presentations and recommendations to senior management for required commercial investment, including marketing, sales and managed markets
- Proven track record interfacing and influencing senior leaders and cross-functional collaboration
- Experience in commercial functions supporting European markets or Japan, such as commercial development, portfolio strategy, pricing/market access or marketing
- 7+ years in management consulting or industry, or combination of relevant experience
- Bachelors in life science and MBA strongly preferred
- Jazz Pharmaceuticals is an Equal Opportunity Employer.
Director of Planning - Cowley, Oxfordshire, United Kingdom - Jazz Pharmaceuticals
Description
Jazz Pharmaceuticals plc (NASDAQ:
For more information, please visit and follow @JazzPharma on Twitter.
This position resides in New Product Planning-Partnerships, reporting directly to the Head of New Product Planning-Partnerships, and will partner directly with Corporate Development, Search & Evaluation, and NPP colleagues to identify and assess the EUR/INT commercial potential and strategic fit of target assets, as well as partner with EUR/INT and Global leadership on portfolio and market access strategy.
Jazz is committed to long-term growth associated with mergers, acquisitions and partnerships, deal flow and potential to complete transactions is high.
Accordingly, for the position requires a self-motivated, strategically agile and unquestioned collaborator to join the New Product Planning-Partnerships team.Lead commercial assessments (e.g., Partner closely and collaboratively with many functions, such as US/EU Commercial, Search and Evaluation, R&D, Regulatory, and Corporate Development for deal assessments and diligence